Chapter/Section Purchase

1 Study Coverage
1.1 Age Related Macular Degeneration Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Age Related Macular Degeneration Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Squalamine
1.2.6 Conercept
1.2.7 Lampalizamab
1.2.8 Others
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 50-60 Years Old
1.3.3 60-70 Years Old
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Age Related Macular Degeneration Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Age Related Macular Degeneration Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Age Related Macular Degeneration Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Age Related Macular Degeneration Drugs Sales by Region
2.4.1 Global Age Related Macular Degeneration Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Age Related Macular Degeneration Drugs by Region (2023-2028)
2.5 Global Age Related Macular Degeneration Drugs Revenue by Region
2.5.1 Global Age Related Macular Degeneration Drugs Revenue by Region (2017-2022)
2.5.2 Global Age Related Macular Degeneration Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Age Related Macular Degeneration Drugs Sales by Manufacturers
3.1.1 Global Top Age Related Macular Degeneration Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Age Related Macular Degeneration Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Age Related Macular Degeneration Drugs in 2021
3.2 Global Age Related Macular Degeneration Drugs Revenue by Manufacturers
3.2.1 Global Age Related Macular Degeneration Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Age Related Macular Degeneration Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration Drugs Revenue in 2021
3.3 Global Age Related Macular Degeneration Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Age Related Macular Degeneration Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Age Related Macular Degeneration Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Age Related Macular Degeneration Drugs Sales by Type
4.1.1 Global Age Related Macular Degeneration Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Age Related Macular Degeneration Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Age Related Macular Degeneration Drugs Sales Market Share by Type (2017-2028)
4.2 Global Age Related Macular Degeneration Drugs Revenue by Type
4.2.1 Global Age Related Macular Degeneration Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Age Related Macular Degeneration Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Age Related Macular Degeneration Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Age Related Macular Degeneration Drugs Price by Type
4.3.1 Global Age Related Macular Degeneration Drugs Price by Type (2017-2022)
4.3.2 Global Age Related Macular Degeneration Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Age Related Macular Degeneration Drugs Sales by Application
5.1.1 Global Age Related Macular Degeneration Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Age Related Macular Degeneration Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Age Related Macular Degeneration Drugs Sales Market Share by Application (2017-2028)
5.2 Global Age Related Macular Degeneration Drugs Revenue by Application
5.2.1 Global Age Related Macular Degeneration Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Age Related Macular Degeneration Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Age Related Macular Degeneration Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Age Related Macular Degeneration Drugs Price by Application
5.3.1 Global Age Related Macular Degeneration Drugs Price by Application (2017-2022)
5.3.2 Global Age Related Macular Degeneration Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Age Related Macular Degeneration Drugs Market Size by Type
6.1.1 North America Age Related Macular Degeneration Drugs Sales by Type (2017-2028)
6.1.2 North America Age Related Macular Degeneration Drugs Revenue by Type (2017-2028)
6.2 North America Age Related Macular Degeneration Drugs Market Size by Application
6.2.1 North America Age Related Macular Degeneration Drugs Sales by Application (2017-2028)
6.2.2 North America Age Related Macular Degeneration Drugs Revenue by Application (2017-2028)
6.3 North America Age Related Macular Degeneration Drugs Market Size by Country
6.3.1 North America Age Related Macular Degeneration Drugs Sales by Country (2017-2028)
6.3.2 North America Age Related Macular Degeneration Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Age Related Macular Degeneration Drugs Market Size by Type
7.1.1 Europe Age Related Macular Degeneration Drugs Sales by Type (2017-2028)
7.1.2 Europe Age Related Macular Degeneration Drugs Revenue by Type (2017-2028)
7.2 Europe Age Related Macular Degeneration Drugs Market Size by Application
7.2.1 Europe Age Related Macular Degeneration Drugs Sales by Application (2017-2028)
7.2.2 Europe Age Related Macular Degeneration Drugs Revenue by Application (2017-2028)
7.3 Europe Age Related Macular Degeneration Drugs Market Size by Country
7.3.1 Europe Age Related Macular Degeneration Drugs Sales by Country (2017-2028)
7.3.2 Europe Age Related Macular Degeneration Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Age Related Macular Degeneration Drugs Market Size by Type
8.1.1 Asia Pacific Age Related Macular Degeneration Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Age Related Macular Degeneration Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Age Related Macular Degeneration Drugs Market Size by Application
8.2.1 Asia Pacific Age Related Macular Degeneration Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Age Related Macular Degeneration Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Age Related Macular Degeneration Drugs Market Size by Region
8.3.1 Asia Pacific Age Related Macular Degeneration Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Age Related Macular Degeneration Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Age Related Macular Degeneration Drugs Market Size by Type
9.1.1 Latin America Age Related Macular Degeneration Drugs Sales by Type (2017-2028)
9.1.2 Latin America Age Related Macular Degeneration Drugs Revenue by Type (2017-2028)
9.2 Latin America Age Related Macular Degeneration Drugs Market Size by Application
9.2.1 Latin America Age Related Macular Degeneration Drugs Sales by Application (2017-2028)
9.2.2 Latin America Age Related Macular Degeneration Drugs Revenue by Application (2017-2028)
9.3 Latin America Age Related Macular Degeneration Drugs Market Size by Country
9.3.1 Latin America Age Related Macular Degeneration Drugs Sales by Country (2017-2028)
9.3.2 Latin America Age Related Macular Degeneration Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Age Related Macular Degeneration Drugs Market Size by Type
10.1.1 Middle East and Africa Age Related Macular Degeneration Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Age Related Macular Degeneration Drugs Market Size by Application
10.2.1 Middle East and Africa Age Related Macular Degeneration Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Age Related Macular Degeneration Drugs Market Size by Country
10.3.1 Middle East and Africa Age Related Macular Degeneration Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Corporation Information
11.2.2 Bayer Healthcare Overview
11.2.3 Bayer Healthcare Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Healthcare Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Healthcare Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Overview
11.3.3 Roche Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Roche Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Neurotech Pharmaceuticals
11.4.1 Neurotech Pharmaceuticals Corporation Information
11.4.2 Neurotech Pharmaceuticals Overview
11.4.3 Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Neurotech Pharmaceuticals Recent Developments
11.5 Regeneron Pharmaceuticals
11.5.1 Regeneron Pharmaceuticals Corporation Information
11.5.2 Regeneron Pharmaceuticals Overview
11.5.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Regeneron Pharmaceuticals Recent Developments
11.6 Allergan
11.6.1 Allergan Corporation Information
11.6.2 Allergan Overview
11.6.3 Allergan Age Related Macular Degeneration Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Allergan Age Related Macular Degeneration Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Allergan Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Age Related Macular Degeneration Drugs Industry Chain Analysis
12.2 Age Related Macular Degeneration Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Age Related Macular Degeneration Drugs Production Mode & Process
12.4 Age Related Macular Degeneration Drugs Sales and Marketing
12.4.1 Age Related Macular Degeneration Drugs Sales Channels
12.4.2 Age Related Macular Degeneration Drugs Distributors
12.5 Age Related Macular Degeneration Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Age Related Macular Degeneration Drugs Industry Trends
13.2 Age Related Macular Degeneration Drugs Market Drivers
13.3 Age Related Macular Degeneration Drugs Market Challenges
13.4 Age Related Macular Degeneration Drugs Market Restraints
14 Key Findings in The Global Age Related Macular Degeneration Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer